Product Formulations Clause Samples

Product Formulations. Senetek shall have the right (but not the obligation) to analyze Enprani's formulations of the Products for compliance with Senetek's efficacy and safety standards, which are as follows: Senetek shall provide its assay method to Enprani to conduct testing of any and all formulations produced and marketed by Enprani to insure that such formulations have less than [***] systemic absorption with a time interval of [***], such testing to utilize either mass spectrometry techniques or radioactive tracers. Senetek is granted with the right of analysis of random samples prior to Enprani's full production of the Product. Senetek reserves the right to update or change testing procedures and shall promptly give Enprani a written notice thereof. Senetek shall be afforded a period of fifteen (15) days upon receipt of the data to provide its written approval or disapproval of such formulations with written reasons for its decision. If no written response is received from Senetek within fifteen(15) days upon receipt of the data, such formulation shall be deemed approved. No approval of any formulation by Senetek shall be deemed an endorsement of such formulation or a determination by Senetek that such product is safe or effective, nor shall the same be implied by Enprani to any person or entity. After the manufacture of the Product has commenced, Enprani shall report to Senetek, from time to time, the analysis results for L random samples of the Units manufactured with lots specified. Senetek shall have the right to audit, at Senetek's expense, random samples of the product formulations once a year during normal business hours, and more frequently if an audit reveals that product formulation standards deviate from those standards stated herein.

Product Formulations. The finished Product formulas and Specifications are owned exclusively by and shall have no rights of ownership in, or use of (except for such limited use as is required to perform its obligations under this Agreement), the Product formulas or Specifications. This includes, without limitation, license rights, excepting the license rights granted herein. Subject to the requirements of Section 3 and Section 23, nothing herein shall prohibit from developing product formulas and specifications within the normal course of conducting its business.

Product Formulations. All formulations developed by Licensee relating to the Products shall be jointly owned by the parties. Upon completion of each such formulation approved by KOOP, Licensee shall deliver to KOOP all necessary and relevant information and documentation, in a mutually acceptable format, relating to each such formulation. The parties agree in good faith to work together to perform all necessary tasks relating to the protection of each party's ownership in the Product formulations.

Product Formulations. Sepracor shall be solely responsible for the formulation, indications, labeling and packaging for the Product. Sepracor may change any formulation, labeling, and/or packaging at its own discretion with thirty (30) days prior written notice to ▇▇▇▇▇▇, unless such change requires pre-approval by the FDA, in which case Sepracor shall obtain ▇▇▇▇▇▇'▇ prior written approval which shall be promptly given and not unreasonably withheld. Sepracor shall be responsible for the cost of such changes and the cost to change any and all Sepracor Promotional Materials.

Product Formulations. The Company has disclosed to Purchaser the percentages by weight of petroleum distillates, volatile organic compounds, Hazardous Materials and certain other (but not all) components for each current formula for the Company's chemical products, together with the Material Data Safety Sheets and product labels for such chemical products. To the Shareholders' knowledge, (i) the product labels for such products comply with Consumer Product Safety Commission guidelines, and (ii) the product formulations are accurately reflected in the disclosures in the Material Safety Data Sheets for these products.